Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Musculoskelet Neuronal Interact ; 17(4): 299-302, 2017 12 01.
Article in English | MEDLINE | ID: mdl-29199189

ABSTRACT

OBJECTIVE: The aim of our study was to compare the biomechanical stability of the Proximal Femoral Nail Antirotation (PFNA) (with 200 mm, 240 mm and 280 mm-long main nails) for the management of unstable intertrochanteric femoral fractures. METHODS: Tronzo-Evans Type IV and V fractures were built by applying a three-dimensional finite element model. Further, PFNA-II with 200 mm, 240 mm and 280 mm-long main nails were applied for fixation. The above model is the creation of 3 researchers designed in order to obtain average values of numerical stress. Von Mises stress distribution and medial and lateral stress peak of the femur and PFNA were compared. RESULTS: 240 mm and 280 mm PFNA medial stress peak was reduced significantly in comparison to 200 mm PFNA (p⟨0.05). However, there was no difference between 240 mm and 280 mm PFN. Also, no statistical difference was observed with any of 3 lengths in both medial and lateral stress peak for Evans Type IV and V PFNA. CONCLUSION: 240 mm and 280 mm PFNA could reduce femur fixation medial stress peak. Further, they were more efficient in comparison to the 200 mm PFNA, and their biomechanical stability was similar to that of the 280 mm nail.


Subject(s)
Biomechanical Phenomena , Bone Nails , Femoral Fractures/surgery , Fracture Fixation, Internal/instrumentation , Adult , Finite Element Analysis , Humans , Male
2.
Osteoarthritis Cartilage ; 23(10): 1763-75, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26028140

ABSTRACT

OBJECTIVE: The purposes of this study were to assess whether local anesthetics (LAs), such as ropivacaine and bupivacaine, could induce apoptosis of rabbit annulus fibrosus (AF) cells in vitro and further to explore the possible underlying mechanism. METHODS: Rabbit AF cells at second passage were treated with saline solution and various concentrations of LAs. Apoptosis of AF cells were examined by cell counting kit-8 (CCK-8), Annexin V assays, Hoechst 33342 staining, and Caspase-3, -9 activity assays. The expression of apoptosis-related markers was detected by real-time PCR (RT-PCR) and Western Blot. The JC-1 staining was used to evaluate the change of mitochondrial membrane potential (MMP). Moreover, the levels of reactive oxygen species (ROS) were determined with fluorescent probe DCFH-DA. RESULTS: The results of flow cytometry indicated that LAs could induce apoptosis of rabbit AF cells in a dose-dependent manner. Apoptosis was confirmed by cell morphology, condensed nuclei and activation of Caspase-3 and -9. In addition, the molecular data showed that LAs could significantly up-regulate the expression of Bax, accompanied by a significant down-regulation of Bcl-2 expression. Furthermore, we also observed that LAs resulted in alteration of MMP and accumulation of intracellular ROS in AF cells. Blockade of ROS production by N-acetyl-l-cysteine (NAC) inhibited LAs-induced apoptosis. CONCLUSIONS: These findings suggest that LAs in clinically relevant concentrations could induce apoptosis of rabbit AF cells in vitro, and the mitochondrial pathway was, at least in part, involved in the LAs-mediated apoptosis. Further investigations focusing on the potential cytotoxicity of LAs on IVD cells are needed.


Subject(s)
Amides/pharmacology , Anesthetics, Local/pharmacology , Apoptosis/drug effects , Bupivacaine/pharmacology , Chondrocytes/drug effects , Intervertebral Disc/drug effects , Mitochondria/drug effects , Animals , Blotting, Western , Caspase 3/drug effects , Caspase 3/genetics , Caspase 3/metabolism , Caspase 9/drug effects , Caspase 9/genetics , Caspase 9/metabolism , Cell Death/drug effects , Cells, Cultured , Down-Regulation/drug effects , In Vitro Techniques , Intervertebral Disc/cytology , Membrane Potential, Mitochondrial/drug effects , Proto-Oncogene Proteins c-bcl-2/drug effects , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Rabbits , Reactive Oxygen Species/metabolism , Real-Time Polymerase Chain Reaction , Ropivacaine
3.
Osteoarthritis Cartilage ; 21(12): 2030-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24120490

ABSTRACT

OBJECTIVE: To determine whether autophagy contributes to the pathogenesis of degenerative disc disease (DDD) or retards the intervertebral disc (IVD) degeneration, and investigate the possible relationship between compression-induced autophagy and intracellular reactive oxygen species (ROS) in nucleus pulposus (NP) cells in vitro. METHODS: The autophagosome and autophagy-related markers were used to explore the role of autophagy in rat NP cells under compressive stress, which were measured directly by electronic microscopy, monodansylcadaverine (MDC) staining, immunofluorescence, western blot, and indirectly by analyzing the impact of pharmacological inhibitors of autophagy such as 3-methyladenine (3-MA) and chloroquine (CQ). And the relationship between autophagy and apoptosis was investigated by Annexin-V/propidium iodide (PI)-fluorescein staining. In addition, ROS were measured to determine whether these factors are responsible for the development of compression-induced autophagy. RESULTS: Our results indicated that rat NP cells activated autophagy in response to the same strong apoptotic stimuli that triggered apoptosis by compression. Autophagy and apoptosis were interconnected and coordinated in rat NP cells exposed to compression stimuli. Compression-induced autophagy was closely related to intracellular ROS production. CONCLUSIONS: Enhanced degradation of damaged components of NP cells by autophagy may be a crucial survival response against mechanical overload, and extensive autophagy may trigger autophagic cell death. Regulating autophagy and reducing the generation of intracellular ROS may retard IVD degeneration.


Subject(s)
Apoptosis/physiology , Autophagy/physiology , Intervertebral Disc Degeneration/metabolism , Intervertebral Disc/cytology , Reactive Oxygen Species/metabolism , Stress, Mechanical , Adenine/analogs & derivatives , Adenine/pharmacology , Animals , Apoptosis/drug effects , Autophagy/drug effects , Blotting, Western , Cells, Cultured , Chloroquine/pharmacology , Immunohistochemistry , Intervertebral Disc/drug effects , Intervertebral Disc/metabolism , Intervertebral Disc Degeneration/pathology , Microscopy, Electron, Transmission , Rats
4.
J Res Natl Inst Stand Technol ; 115(6): 433-6, 2010.
Article in English | MEDLINE | ID: mdl-27134795

ABSTRACT

We describe the results of a comparison of reference standards between the National Institute of Standards and Technology (NIST-USA) and National Institute of Metrology (NIM-China). We report optical fiber-based power measurements at nominal wavelengths of 1310 nm and 1550 nm. We compare the laboratories' reference standards by means of a commercial optical power meter. Measurement results showed the largest difference of less than 2.6 parts in 10(3), which is within the combined standard (k = 1) uncertainty for the laboratories' reference standards.

5.
Endocrinology ; 126(4): 2102-9, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2156681

ABSTRACT

To gain insight into the regulation of low Km cAMP phosphodiesterases (PDE) by insulin in human tissues, PDEs in human placenta were studied. Human placenta contained cAMP PDEs in particulate and cytosolic fractions. More than 99% of the total activity was localized in the cytosolic fraction. The cytosolic fraction exhibited at least four cyclic nucleotide PDEs when fractionated by DEAE-cellulose chromatography. The first form was a calmodulin-activated PDE which hydrolyzed both cGMP and cAMP. The second form was a high affinity cAMP PDE with a nonlinear kinetic characteristic, but was not inhibited by either cGMP or cilostamide (either compound is known to specifically inhibit rat insulin-sensitive cAMP PDE). The third form was a low Km cAMP PDE, but was only modestly sensitive to inhibition by cGMP or cilostamide. The fourth form was a cAMP PDE which showed high sensitivity to inhibition by cGMP or cilostamide. The IC50 values of the fourth form were comparable to those of rat adipose insulin-sensitive PDE. However, its Km for cAMP was 2 microM, which is about 10 times higher than that of the rat enzyme. Insulin treatment on placenta tissues stimulated at least two PDEs, the third and fourth forms. To our knowledge, this is the first report to describe insulin-sensitive cAMP PDEs in the cytosolic fraction of human placenta.


Subject(s)
3',5'-Cyclic-AMP Phosphodiesterases/metabolism , Cytosol/enzymology , Insulin/pharmacology , Placenta/enzymology , 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , Cyclic AMP/metabolism , Female , Humans , Hydrolysis , Pregnancy , Quinolones/pharmacology , Subcellular Fractions/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL